Real Time
BOERSE MUENCHEN
15:45:21 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
84,85
EUR
|
+0,89%
|
|
-2,10%
|
-11,60%
|
Fiscaal tijdperk: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
6.837
|
16.071
|
54.764
|
34.112
|
22.730
|
20.545
|
-
|
-
|
Bedrijfswaarde
1 |
6.318
|
14.964
|
53.372
|
20.449
|
22.730
|
5.770
|
6.785
|
7.902
|
K/w-verhouding
|
-35,6
x
|
1.112
x
|
5,72
x
|
3,72
x
|
25
x
|
-49
x
|
-43,5
x
|
-40,3
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
63
x
|
33,3
x
|
2,89
x
|
1,97
x
|
5,95
x
|
7,34
x
|
7,43
x
|
7,31
x
|
Bedrijfswaarde/omzet
|
58,2
x
|
31
x
|
2,81
x
|
1,18
x
|
5,95
x
|
2,06
x
|
2,45
x
|
2,81
x
|
Bedrijfswaarde/EBITDA
|
-42,8
x
|
-343
x
|
3,47
x
|
1,6
x
|
26
x
|
-6,58
x
|
-8,09
x
|
-8,16
x
|
Bedrijfswaarde/FCF
|
-26,6
x
|
-188
x
|
72,5
x
|
1,55
x
|
-
|
37,5
x
|
-9,41
x
|
-9,32
x
|
FCF Yield
|
-3,75%
|
-0,53%
|
1,38%
|
64,6%
|
-
|
2,67%
|
-10,6%
|
-10,7%
|
Price to Book
|
13,9
x
|
11,8
x
|
4,62
x
|
1,7
x
|
-
|
1,04
x
|
1,04
x
|
1,1
x
|
Aantal aandelen (in duizenden)
|
226.262
|
240.786
|
241.521
|
243.019
|
237.716
|
241.319
|
-
|
-
|
Referentieprijs
2 |
30,22
|
66,74
|
226,7
|
140,4
|
95,62
|
85,14
|
85,14
|
85,14
|
Datum van publicatie
|
31/03/20
|
30/03/21
|
30/03/22
|
27/03/23
|
20/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
108,6
|
482,3
|
18.977
|
17.311
|
3.819
|
2.800
|
2.766
|
2.810
|
EBITDA
1 |
-147,6
|
-43,67
|
15.359
|
12.766
|
873,8
|
-877,4
|
-838,7
|
-967,9
|
Bedrijfsresultaat (EBIT)
1 |
-181,5
|
-82,42
|
15.284
|
12.643
|
690,4
|
-1.020
|
-981
|
-1.031
|
Operationele Marge
|
-167,16%
|
-17,09%
|
80,54%
|
73,03%
|
18,08%
|
-36,44%
|
-35,47%
|
-36,7%
|
Resultaat voor belastingen (EBT)
1 |
-179,4
|
-145,8
|
15.046
|
12.954
|
1.186
|
-391,2
|
-565,9
|
-530,6
|
Nettowinst (verlies)
1 |
-179,1
|
15,2
|
10.292
|
9.434
|
930,3
|
-414,8
|
-490,7
|
-534,2
|
Nettomarge
|
-164,89%
|
3,15%
|
54,24%
|
54,5%
|
24,36%
|
-14,82%
|
-17,74%
|
-19,01%
|
WPA
2 |
-0,8500
|
0,0600
|
39,63
|
37,77
|
3,830
|
-1,737
|
-1,957
|
-2,111
|
Free Cash Flow
1 |
-237,1
|
-79,51
|
735,7
|
13.214
|
-
|
153,8
|
-721,2
|
-847,6
|
FCF-marge
|
-218,37%
|
-16,48%
|
3,88%
|
76,34%
|
-
|
5,49%
|
-26,08%
|
-30,16%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
4,79%
|
103,51%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
7,15%
|
140,06%
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
31/03/20
|
30/03/21
|
30/03/22
|
27/03/23
|
20/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
6.087
|
5.532
|
6.375
|
3.196
|
3.461
|
4.278
|
1.277
|
167,7
|
895,3
|
1.479
|
187,6
|
109,4
|
485,1
|
1.962
|
124,5
|
EBITDA
1 |
4.743
|
4.726
|
-
|
-
|
2.421
|
3.322
|
685,8
|
-
|
114,4
|
605
|
-468,9
|
-660
|
-290
|
824
|
-
|
Bedrijfsresultaat (EBIT)
1 |
4.724
|
4.700
|
4.753
|
2.210
|
2.388
|
3.293
|
654,4
|
-563,3
|
73,1
|
526,2
|
-507,2
|
-656,3
|
-383,7
|
579,6
|
-709,2
|
Operationele Marge
|
77,6%
|
84,95%
|
74,56%
|
69,13%
|
68,98%
|
76,97%
|
51,25%
|
-335,9%
|
8,16%
|
35,58%
|
-270,36%
|
-600,09%
|
-79,11%
|
29,54%
|
-569,67%
|
Resultaat voor belastingen (EBT)
1 |
4.667
|
4.714
|
5.018
|
2.319
|
2.444
|
3.173
|
707,7
|
-412,2
|
227,4
|
663,2
|
-331,8
|
-502,5
|
-235,7
|
764,7
|
-522,6
|
Nettowinst (verlies)
1 |
3.211
|
3.166
|
3.699
|
1.672
|
1.785
|
2.279
|
502,2
|
-190,4
|
160,6
|
457,9
|
-315,1
|
-459,4
|
-261,5
|
698,2
|
-522,6
|
Nettomarge
|
52,75%
|
57,23%
|
58,02%
|
52,31%
|
51,57%
|
53,26%
|
39,33%
|
-113,54%
|
17,94%
|
30,96%
|
-167,96%
|
-420,01%
|
-53,91%
|
35,58%
|
-419,74%
|
WPA
2 |
12,35
|
12,18
|
14,24
|
6,450
|
6,980
|
9,260
|
2,050
|
-0,7900
|
0,6700
|
1,900
|
-1,310
|
-2,059
|
-1,380
|
2,988
|
-1,796
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
9/11/21
|
30/03/22
|
9/05/22
|
8/08/22
|
7/11/22
|
27/03/23
|
8/05/23
|
7/08/23
|
6/11/23
|
20/03/24
|
6/05/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
519
|
1.107
|
1.391
|
13.663
|
-
|
14.775
|
13.761
|
12.644
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-237
|
-79,5
|
736
|
13.214
|
-
|
154
|
-721
|
-848
|
ROE (netto-inkomsten/eigen vermogen)
|
-47,1%
|
1,63%
|
155%
|
59,1%
|
-
|
-3,03%
|
-2,26%
|
-3,62%
|
ROA (netto-inkomsten/totale activa)
|
-24,7%
|
0,98%
|
113%
|
48,2%
|
-
|
-1,99%
|
-2,66%
|
-4,02%
|
Totale activa
1 |
725,3
|
1.558
|
9.075
|
19.555
|
-
|
20.892
|
18.470
|
13.272
|
Nettoactief per aandeel
2 |
2,180
|
5,680
|
49,00
|
82,50
|
-
|
81,70
|
81,70
|
77,30
|
Cashflow per aandeel
2 |
-0,9400
|
-0,0500
|
3,430
|
55,80
|
-
|
4,640
|
0,6200
|
0,0300
|
Capex
1 |
38,6
|
66
|
128
|
329
|
-
|
404
|
353
|
315
|
Capex/omzet
|
35,54%
|
13,69%
|
0,67%
|
1,9%
|
-
|
14,45%
|
12,76%
|
11,21%
|
Datum van publicatie
|
31/03/20
|
30/03/21
|
30/03/22
|
27/03/23
|
20/03/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
85,14
EUR Gemiddelde koersdoel
105,4
EUR Spread / Gemiddelde doel +23,78% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +9,39% | 115 mld. | | +12,20% | 107 mld. | | -3,64% | 21,6 mld. | | -6,72% | 18,23 mld. | | -38,57% | 17,62 mld. | | +7,35% | 14,26 mld. | | +34,93% | 12,37 mld. | | -24,39% | 8,28 mld. | | +20,54% | 8,26 mld. |
Biotherapeutische geneesmiddelen
|